Reply to: Suspected black cohosh hepatotoxicity-Causality assessment versus safety signal. Quality versus quantity

Maturitas

Volumn 64, Issue 2, 2009, Pages 141-142

  Teschke, Rolf ^a   Bahre, Ruediger ^a   Genthner, Alexander ^a   Fuchs, Johannes ^a   Schmidt Taenzer, Wolfgang ^a   Wolff, Albrecht ^a  

^a Klinikum Hanau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM PHOSPHATE; CIMICIFUGA RACEMOSA EXTRACT; HYPERICUM PERFORATUM EXTRACT; IRBESARTAN; LEVOTHYROXINE; METHYLPREDNISOLONE; PUERARIA EXTRACT; RED CLOVER EXTRACT; SIMVASTATIN;

GENOTYPE; LETTER; LIVER TOXICITY; PATIENT SAFETY; RISK ASSESSMENT; SOYBEAN; YAM;

CIMICIFUGA DAHURICA;

EID: 70349832269     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.08.006     Document Type: Letter

References (14)

1. Mahady G., Low Dog T., Sarma D.N., and Giancaspro G. Suspected black cohosh hepatotoxiciy-causality assessment versus safety signal, quality versus quantity. Maturitas 64 (2009) 139-140
2. Teschke R., and Schwarzenboeck A. Suspected hepatotoxicity by Cimicifugae racemosae rhizome (black cohosh, root): critical analysis and structured causality assessment. Phytomedicine 16 (2009) 72-84
3. Teschke R., Bahre R., Fuchs J., et al. Black cohosh hepatotoxicity: qantitative causality evaluation in nine suspected cases. Menopause 16 (2009) 956-965
4. Teschke R., Bahre R., Genthner A., et al. Suspected black cohosh hepatotoxicity-challenges and pitfalls of causality assessment. Maturitas 63 (2009) 302-314
5. Vannacci A., Lapi F., Gallo E., et al. A case of hepatitis associated with long-term use of Cimicifuga racemosa. Altern Ther Health Med 15 (2009) 62-63
6. Pierard S., Coche J.S., Lanthier P., et al. Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Eur J Gastroenterol Hepatol 21 (2009) 941-945
7. Teschke R. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 16 (2009) 214 [Letter to the Editor]
8. Mahady G., Low Dog T., Barrett M.L., et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 15 (2008) 628-638
9. Mahady G., Low Dog T., and Sarma D.N. Letter to the Editor (Reply). Menopause 16 (2009) 214-215
10. Garcia-Cortés M., Lucena M.I., Pachkoria K., et al. Evaluation of the Naranjo adverse drug reactions probability scale in the causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 27 (2008) 780-789
11. EMEA, Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizome (black cohosh, root). Available at: http://www.emea.eu/pdfs//human/hmpc/26925806en.pdf. Accessed July 18, 2006.
12. Rochon J., Protiva P., Seeff L.B., et al. Reliability of the Roussel Uclaf causality assessment method for assessing causality in drug-induced liver injury. Hepatology 48 (2008) 1175-1183
13. Chalasani N., Fontana R.J., and Bonkovsky H.L. Causes, clinical features, and outcomes from a prospective of drug-induced liver injury in the United States. Gastroenterology 135 (2008) 1924-1934
14. Björnsson E., and Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42 (2005) 481-489